Microbial Factories for the Production of Benzylisoquinoline Alkaloids

Trends Biotechnol. 2016 Mar;34(3):228-241. doi: 10.1016/j.tibtech.2015.12.005. Epub 2016 Jan 15.

Abstract

Benzylisoquinoline alkaloids (BIAs) are a family of ∼2500 alkaloids with both potential and realized pharmaceutical value, including most notably the opiates such as codeine and morphine. Only a few BIAs accumulate readily in plants, which limits the pharmaceutical potential of the family. Shifting BIA production to microbial sources could provide a scalable and flexible source of these compounds in the future. This review details the current status of microbial BIA synthesis and derivatization, including rapid developments in the past 6 months culminating in the synthesis of opioids from glucose in a microbial host.

Keywords: aromatic amino acids; benzylisoquinoline alkaloids; biosecurity; dopamine; microbial synthesis; morphinans.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Benzylisoquinolines / chemistry
  • Benzylisoquinolines / metabolism*
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • Metabolic Engineering*
  • Saccharomyces cerevisiae* / genetics
  • Saccharomyces cerevisiae* / metabolism

Substances

  • Benzylisoquinolines